OraSure Technologies (OSUR)
(Delayed Data from NSDQ)
$4.18 USD
+0.08 (1.95%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $4.19 +0.01 (0.24%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
OraSure Technologies (OSUR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$6.38 | $9.00 | $4.50 | 55.61% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for OraSure Technologies comes to $6.38. The forecasts range from a low of $4.50 to a high of $9.00. The average price target represents an increase of 55.61% from the last closing price of $4.10.
Analyst Price Targets (4 )
Broker Rating
OraSure Technologies currently has an average brokerage recommendation (ABR) of 2.60 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 2.60 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, one is Strong Buy, representing 20% of all recommendations. A month ago, Strong Buy represented 20%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/OSUR.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 4 | 4 | 4 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.60 | 2.60 | 2.60 | 2.67 | 2.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/3/2024 | Stephens | Jacob Johnson | Hold | Hold |
4/4/2024 | Evercore Partners | Vijay Kumar | Hold | Hold |
12/11/2023 | Not Identified | Not Identified | Not Available | Strong Buy |
11/13/2023 | Not Identified | Not Identified | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.60 |
ABR (Last week) | 2.60 |
# of Recs in ABR | 5 |
Average Target Price | $6.38 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 170 of 252 |
Current Quarter EPS Est: | 0.03 |